After high hopes, it doesn’t look like Ariad Pharmaceuticals’ Iclusig will be able to compete with leukemia drugs from Novartis and Bristol-Myers Squibb.
After high hopes, it doesn’t look like Ariad Pharmaceuticals’ Iclusig will be able to compete with leukemia drugs from Novartis and Bristol-Myers Squibb.